SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057898
Filing Date
2017-11-13
Accepted
2017-11-13 06:11:02
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv478746_10q.htm 10-Q 320716
2 EXHIBIT 31.1 tv478746_ex31-1.htm EX-31.1 10176
3 EXHIBIT 31.2 tv478746_ex31-2.htm EX-31.2 10097
4 EXHIBIT 32.1 tv478746_ex32-1.htm EX-32.1 3965
5 EXHIBIT 32.2 tv478746_ex32-2.htm EX-32.2 4120
  Complete submission text file 0001144204-17-057898.txt   2262220

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycc-20170930.xml EX-101.INS 311850
7 XBRL TAXONOMY EXTENSION SCHEMA cycc-20170930.xsd EX-101.SCH 29018
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cycc-20170930_cal.xml EX-101.CAL 28176
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20170930_def.xml EX-101.DEF 108266
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20170930_lab.xml EX-101.LAB 279307
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20170930_pre.xml EX-101.PRE 184435
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 171192719
SIC: 2834 Pharmaceutical Preparations